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BACKGROUND SYNTAX score is an objective scoring system to assess
severity and extent coronary artery disease. To evaluate the prog-
nostic value of the SYNTAX score in predicting in-hospital mortality in
coronary artery bypass patients, at a tertiary center in India.
METHODS A cohort of 325 patients who underwent Coronary Artery
Bypass surgery was included in this study from June 2011 to May 2014.
They were divided into tertiles according to the SYNTAX score (0-22,
23-33 and above 33). The endpoint was in-hospital mortality.
RESULTS The mortality in SS tertiles were as follows; 0-22¼6%;
23-33¼4.2% and above 33¼14.3%. There was signiﬁcant increase in
mortality in the third tertile (p¼0.0297). SS above 33 had an Odd’s
ratio of 3.036 (p¼0.018) for mortality.
CONCLUSION Severity of coronary artery disease as measured by
Syntax Score of more than 33 is a signiﬁcant predictor of mortality
after Coronary Artery Bypass surgery.
TCTAP A-166
Effects of Obesity and Metabolic Abnormality on the Risk of Cardiovascular
Disease in the Population of the City of Marrakech
Khramaz Mounia1
1CHU Mohamed VI, UCAM, FMPM, PCIM, Morocco
BACKGROUND We aimed to investigate combined effects of obesity
and metabolic abnormality on the risk of cardiovascular disease and
mortality in adults of the city of Marrakech.
METHODS This is a cross-sectional study conducted in 2013 to 2014
among a representative sample of adults in the city of Marrakech in
Morocco. Anthropometric and blood pressure measurements were
collected, and a blood sample was taken. The prevalence of obesity
(body mass index30 kg/m2) and abdominal obesity (waist circum-
ference>102 cm in males or >88 cm in females) was determined. The
inﬂuence of obesity on estimation of the risk of ischemic heart disease
was studied using the Framingham function. A question about the
social status, dietary habits and physical activity were used.
RESULTS A total of 1198 adults (18-75 years) were included in this study
of which 634 were women (39% with menopause). The prevalence of
obesity was 46% (20% has bodymass index> 40 kg/m2). The prevalence
of obesity was 46% (20% has body mass index >40 kg/m2) and the
prevalence of abdominal obesitywas 37%, that typeof obesitywas higher
in women at 54, 1% than in men. The prevalence of hypertension was
higher in obese (39% of obese against 19, 6% of non-obese). Compared
with healthy normal-weight individuals, metabolically healthy over-
weight and obese individuals showed increased risk for hypertension,
coronary artery disease and diabetes. Metabolically abnormal obese in-
dividuals were at the highest risk for cardiovascular diseases.
CONCLUSION Obesity is a complex multifactorial chronic disease
developing from interactive inﬂuences of numerous factors (social,
behavioral, physiological, metabolic, cellular, and molecular); it’s
common in adults and increases the risk of cardiovascular disease and
premature death. We are in need to expand the detection of obesity
and metabolic abnormality by practitioners and raise awareness about
the importance of good eating habits and sports.
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BACKGROUND The study primary aims to assess patients’ adherence
to evidence based medications (EBM) in terms of dual antiplatelet,
beta blockers (BB), angiotensin converting enzyme inhibitors (ACEI)the angiotensin receptor blockers (ARB) and statins post drug eluting
(DES) and bare metal (BMS) coronary stenting.
METHODS A retrospective cohort study for patients who underwent
percutaneous coronary intervention (PCI) using DES or BMS was con-
ducted at the Heart Hospital, Hamad Medical Corporation, Qatar. Pa-
tients’ demographics, risk factors, clinical presentation, discharge and
outpatient’s follow-up medications were analyzed and compared. End
points included adherence to EBM, re-admission and mortality rate.
RESULTS A total of 557 consecutive PCI patients were enrolled with a
mean age of 5310, of them 85% were males. DES was deployed in 61%
of cases that were mainly used for NSTE-ACS and elective admission.
Language barrier was signiﬁcantly observed within the BMS group
(p¼0.01). Physician compliance to dual antiplatelet, BB, and Statin
was 100% at discharge for both types of stents. The Patients’ adher-
ence to those medications post-discharge was non-signiﬁcantly higher
in DES group (82% vs. 79%), whereas patients adherence over 1 year
was non-signiﬁcantly higher in BMS group (78% vs. 73%). There
admission rate and mortality within 18 months were comparable be-
tween the 2groups (Table 1).
CONCLUSION Despite high adherence to EBM on discharge, 20% of
post PCI patients failed to ﬁll their ﬁrst prescription, irrespective of
their co-morbidities, social economic class or the type of stent. The
majority of those who adhere to the ﬁrst reﬁll continue to take their
medication sat 1 year; these ﬁndings suggest the importance of early
clinic follow up after PCI. As readmission rate is high, further studies
are needed to address patients’ compliance and education.DES (61%) BMS(39) P valueAge 5310 5311 0.22
Arabs 40% 38% 0.75Sex (females) 12% 19% 0.02Low Socioeconomic
class48% 50% 0.55Language barrier 15% 23% 0.01Ist reﬁll* for dual
antiplatelet, BB,
Statins, and ACEI/
ARB81% 79% 0.43Adherence over one
year73% 78% 0.2PPI on discharge 69% 65% 0.25polypharmacy** 83% 87% 0.28Diabetes mellitus 35% 36% 0.91Hypertension 41% 41% 1No visit in 1st year 16% 35% 0.001 for each3 OPD visits 46% 25%
Reason for PCISTEMI 30% 50% 0.001 for allNSTEMI 31% 29%Unstable angina 30% 18%Elective admission 9% 2%Readmission within 18
months24.70% 29% 0.15Mortality 18 months 2.4 2.6 0.97*¼ within 2-3 months post discharge, **¼>5 medication on discharge.
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BACKGROUND Beta-blocker therapy has been shown to beneﬁt pa-
tients presenting with acute myocardial infarction (AMI) or left ven-
tricular (LV) dysfunction. However, whether Beta-blockers provide a
similar beneﬁt in stable coronary artery disease (SCAD) patients with
normal LV function is unknown.
